Department of Anatomy and Neurobiology, University of California, Irvine, California 92697-4625, United States.
Department of Pharmaceutical Sciences, University of California, Irvine, California 92697-4625, United States.
J Med Chem. 2020 Jul 23;63(14):7475-7490. doi: 10.1021/acs.jmedchem.0c00191. Epub 2020 Mar 26.
-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase primarily found in the endosomal-lysosomal compartment of innate and adaptive immune cells. NAAA catalyzes the hydrolytic deactivation of palmitoylethanolamide (PEA), a lipid-derived peroxisome proliferator-activated receptor-α (PPAR-α) agonist that exerts profound anti-inflammatory effects in animal models. Emerging evidence points to NAAA-regulated PEA signaling at PPAR-α as a critical control point for the induction and the resolution of inflammation and to NAAA itself as a target for anti-inflammatory medicines. The present Perspective discusses three key aspects of this hypothesis: the role of NAAA in controlling the signaling activity of PEA; the structural bases for NAAA function and inhibition by covalent and noncovalent agents; and finally, the potential value of NAAA-targeting drugs in the treatment of human inflammatory disorders.
酰乙醇胺酸 amidase(NAAA)是一种 N 端半胱氨酸水解酶,主要存在于固有免疫和适应性免疫细胞的内体溶酶体区室中。NAAA 催化棕榈酰乙醇酰胺(PEA)的水解失活,PEA 是一种脂质衍生的过氧化物酶体增殖物激活受体-α(PPAR-α)激动剂,在动物模型中具有显著的抗炎作用。新出现的证据表明,NAAA 调节的 PEA 信号转导在 PPAR-α 作为炎症诱导和解决的关键控制点,以及 NAAA 本身作为抗炎药物的靶点。本观点讨论了这一假设的三个关键方面:NAAA 在控制 PEA 信号转导活性中的作用;NAAA 功能和共价及非共价抑制剂的结构基础;最后,NAAA 靶向药物在治疗人类炎症性疾病中的潜在价值。